Adams, Phillip

Naltrexone in autistic children: Behavioral symptoms and attentional learning

CAMPBELL, M., ANDERSON, L. T., SMALL, A. M., ADAMS, P., GONZALEZ, N. M., & ERNST, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry

Autism Spectrum Disorder ResearchAttention Deficit Hyperactivity Disorder

Cited by 210

Effect of intrinsic patterns of functional brain connectivity in moderating antidepressant treatment response in major depression

Chin Fatt, C. R., Jha, M. K., Cooper, C. M., Fonzo, G., South, C., Grannemann, B., Carmody, T., Greer, T. L., Kurian, B., Fava, M., et al. (2020) · American Journal of Psychiatry

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 125

Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study

Webb, C. A., Dillon, D. G., Pechtel, P., Goer, F. K., Murray, L., Huys, Q. J., Fava, M., McGrath, P. J., Weissman, M., Parsey, R., et al. (2016) · Neuropsychopharmacology

Treatment of Major DepressionNeural and Behavioral Psychology Studies

Cited by 103

Moderation of the relationship between reward expectancy and prediction error-related ventral striatal reactivity by anhedonia in unmedicated major depressive disorder: findings from the EMBARC study

Greenberg, T., Chase, H. W., Almeida, J. R., Stiffler, R., Zevallos, C. R., Aslam, H. A., Deckersbach, T., Weyandt, S., Cooper, C., Toups, M., et al. (2015) · American Journal of Psychiatry

Neural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 93

Naltrexone in autistic children: An acute open dose range tolerance trial

CAMPBELL, M., OVERALL, J. E., SMALL, A. M., SOKOL, M. S., SPENCER, E. K., ADAMS, P., FOLTZ, R. L., MONTI, K. M., PERRY, R., NOBLER, M., et al. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry

Autism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

Cited by 93

Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR)

Strug, L. J., Suresh, R., Fyer, A. J., Talati, A., Adams, P. B., Li, W., Hodge, S. E., Gilliam, T. C., & Weissman, M. M. (2010) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 87

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

Bartlett, E. A., DeLorenzo, C., Sharma, P., Yang, J., Zhang, M., Petkova, E., Weissman, M., McGrath, P. J., Fava, M., Ogden, R. T., et al. (2018) · Neuropsychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 72